Loading...
Loading...
Among the 8 tracked institutional investors we monitor, DNA (GINKGO BIOWORKS HOLDINGS INC) is held with a combined value of $80.78M across 12,146,211 shares. The largest holder is VANGUARD GROUP INC with a position worth $24.11M (0.00% of their portfolio). 2 funds opened new positions in the most recent quarter. 3 funds increased their holdings. 2 funds reduced their position.
Total Institutional Value
$80.78M
Total Shares Held
12,146,211
Institutional Holders
8
| # | Fund | Value↓ | Portfolio % | Change |
|---|---|---|---|---|
| 1 | VANGUARD GROUP INC | $24.11M | 0.00% | New |
| 2 | BlackRock, Inc. | $22.33M | 0.00% | +1.9% |
| 3 | VIKING GLOBAL INVESTORS LP | $21.93M | 0.06% | - |
| 4 | STATE STREET CORP | $8.26M | 0.00% | +4.2% |
| 5 | MILLENNIUM MANAGEMENT LLC | $2.99M | 0.00% | +897.8% |
| 6 | RENAISSANCE TECHNOLOGIES LLC | $615.79K | 0.00% | New |
| 7 | CITADEL ADVISORS LLC | $543.73K | 0.00% | -57.5% |
| 8 | FMR LLC | $12.33K | 0.00% | -48.6% |
As of the latest SEC 13F filings, VANGUARD GROUP INC is the largest institutional holder of DNA with a position worth $24.11M, representing 0.00% of their portfolio. In total, 8 institutional investors hold DNA with a combined value of $80.78M.
In the most recent quarter, 2 funds opened a new position in DNA. Additionally, 3 increased their holdings and 2 reduced their positions.
Institutional investors hold $80.78M worth of DNA stock across 8 positions. The largest institutional holder is VANGUARD GROUP INC with $24.11M in holdings.
A 13F filing is a quarterly report required by the SEC from institutional investment managers with over $100 million in assets. It discloses their holdings in U.S. equities. For DNA, these filings reveal which major funds are accumulating or reducing positions, providing insights into institutional sentiment.
Get notified when hedge funds change their DNA positions.